Description
Founded in 2010, Portola Capital Partners is a venture capital firm based in New York, New York. The firm seeks to make investments in emerging public and private biotechnology and device companies. healthcare and advisory firm in North America, Asia, Europe, and emerging markets.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Aptinyx | 15-Sep-2015 | Seed Round | Drug Discovery | Generating Revenue/Not Profitable | ||
000000 | 02-Dec-2014 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Aptinyx | 21-Jun-2018 | IPO | 00000 |
000000 | 28-Aug-2015 | 000000000000000000 | 00.000 |